◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Sernova Biotherapeutics Inc

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q4 2025Oct 31, 2025 Q3 2025Jul 31, 2025 Q2 2025Apr 30, 2025 Q1 2025Jan 31, 2025 Q4 2024Oct 31, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00
Operating Revenue 0.00 0.00 0.00 0.00 0.00
Selling General And Administration 1.6M 1.8M 2.0M 2.2M 2.0M
General And Administrative Expense 1.6M 1.8M 2.0M 2.2M 2.0M
Research And Development 809,633 1.7M 2.4M 2.6M 2.7M
Depreciation And Amortization In Income Statement 3,116 3,116 7,229 7,229 10,118
Operating Expense 2.4M 3.5M 4.3M 4.8M 4.7M
Operating Income -2.4M -3.5M -4.3M -4.8M -4.7M
EBIT -2.5M -3.5M -3.5M -5.5M -4.8M
Interest Expense -260,569 541,676 238,728 234,978 199,739
Interest Expense Non Operating -260,569 541,676 238,728 234,978 199,739
Interest Income 27.00 131.00 2,027 23,449 51,096
Interest Income Non Operating 27.00 131.00 2,027 23,449 51,096
Net Interest Income 260,596 -541,545 -236,701 -211,529 -148,643
Other Income Expense -116,566 -11,216 823,078 -677,128 -129,130
Special Income Charges 4,252 50,963 0.00 0.00 0.00
Gain On Sale Of Security -120,818 -62,179 823,078 -677,128 -129,130
Pretax Income -2.3M -4.1M -3.7M -5.7M -5.0M
Tax Provision -54,971 21,124 36,878 6,400 --
Tax Effect Of Unusual Items -2,845 -1,682 123,462 -101,569 0.00
Net Income From Continuing And Discontinued Operation -2.2M -4.1M -3.8M -5.7M -5.0M
Net Income From Continuing Operation Net Minority Interest -2.2M -4.1M -3.8M -5.7M -5.0M
Net Income Including Noncontrolling Interests -2.2M -4.1M -3.8M -5.7M -5.0M
Net Income Common Stockholders -2.2M -4.1M -3.8M -5.7M -5.0M
Net Income -2.2M -4.1M -3.8M -5.7M -5.0M
EBITDA -2.5M -3.3M -3.5M -5.4M -4.6M
Normalized EBITDA -2.3M -3.3M -4.3M -4.7M -4.5M
Reconciled Depreciation 62,215 185,052 47,662 47,662 170,453
Basic EPS -- -0.01 -0.01 -0.02 --
Diluted EPS -- -0.01 -0.01 -0.02 --
Basic Average Shares -- 328.5M 328.5M 327.5M --
Diluted Average Shares -- 328.5M 328.5M 327.5M --
Total Unusual Items -116,566 -11,216 823,078 -677,128 -129,130
Total Unusual Items Excluding Goodwill -116,566 -11,216 823,078 -677,128 -129,130
Tax Rate For Calcs 0.02 0.15 0.15 0.15 0.00
Normalized Income -2.1M -4.1M -4.5M -5.1M -4.8M
Depreciation Amortization Depletion Income Statement 3,116 3,116 7,229 7,229 10,118
Depreciation Income Statement 3,116 3,116 7,229 7,229 10,118
Diluted NI Availto Com Stockholders -2.2M -4.1M -3.8M -5.7M -5.0M
Gain On Sale Of Ppe 4,252 50,963 0.00 0.00 0.00
Insurance And Claims 98,837 110,852 101,801 194,953 129,196
Net Income Continuous Operations -2.2M -4.1M -3.8M -5.7M -5.0M
Net Non Operating Interest Income Expense 260,596 -541,545 -236,701 -211,529 -148,643
Other Gand A 367,870 482,172 564,962 700,016 1.1M
Salaries And Wages 1.1M 1.2M 1.3M 1.3M 735,489
Total Expenses 2.4M 3.5M 4.3M 4.8M 4.7M
Line Item Q4 2025Oct 31, 2025 Q3 2025Jul 31, 2025 Q2 2025Apr 30, 2025 Q1 2025Jan 31, 2025 Q4 2024Oct 31, 2024
Cash And Cash Equivalents 265,004 83,617 2.0M 1.2M 6.0M
Cash Cash Equivalents And Short Term Investments 265,004 83,617 2.0M 1.2M 6.0M
Cash Financial 265,004 83,617 2.0M 1.2M 6.0M
Other Short Term Investments -- -- -- -- 0.00
Accounts Receivable -- 266,048 432,979 373,288 --
Receivables 122,633 266,048 432,979 373,288 298,104
Other Current Assets 135,013 150,086 480,438 487,407 159,170
Current Assets 522,650 499,751 2.9M 2.1M 6.5M
Gross PPE 212,535 187,108 738,607 786,269 1.4M
Accumulated Depreciation -194,811 -- -- -- -600,312
Net PPE 17,724 187,108 738,607 786,269 833,931
Goodwill And Other Intangible Assets -- -- -- -- 0.00
Total Non Current Assets 241,584 410,968 962,467 1.0M 1.1M
Total Assets 764,234 910,719 3.9M 3.1M 7.5M
Current Debt 3.7M 3.6M 3.4M -- --
Current Debt And Capital Lease Obligation 3.7M 3.7M 3.5M 106,206 101,456
Accounts Payable 5.2M -- -- -- 17.2M
Payables 6.7M -- -- -- 18.2M
Payables And Accrued Expenses 8.6M 20.7M 19.8M 20.5M 19.9M
Current Accrued Expenses 1.9M -- -- -- 1.7M
Other Current Liabilities 3.7M -- -- -- --
Current Liabilities 24.8M 24.4M 23.3M 20.6M 20.0M
Long Term Debt 1.0M 943,195 806,833 -- --
Long Term Debt And Capital Lease Obligation 1.0M 975,672 1.2M 440,262 468,484
Long Term Capital Lease Obligation 0.00 32,477 410,196 440,262 468,484
Total Non Current Liabilities Net Minority Interest 1.0M 975,672 1.2M 440,262 468,484
Total Liabilities Net Minority Interest 25.8M 25.3M 24.5M 21.0M 20.5M
Common Stock 118.7M 118.1M 118.1M 118.1M 116.7M
Capital Stock 118.7M 118.1M 118.1M 118.1M 116.7M
Additional Paid In Capital 21.8M 21.0M 20.7M 20.0M 20.7M
Retained Earnings -166.1M -163.9M -159.8M -156.1M -150.4M
Common Stock Equity -25.1M -24.4M -20.7M -17.9M -13.0M
Stockholders Equity -25.1M -24.4M -20.7M -17.9M -13.0M
Total Equity Gross Minority Interest -25.1M -24.4M -20.7M -17.9M -13.0M
Total Capitalization -24.0M -23.5M -19.9M -17.9M -13.0M
Net Tangible Assets -25.1M -24.4M -20.7M -17.9M -13.0M
Tangible Book Value -25.1M -24.4M -20.7M -17.9M -13.0M
Working Capital -24.3M -23.9M -20.4M -18.5M -13.5M
Invested Capital -20.3M -19.8M -16.4M -17.9M -13.0M
Total Debt 4.8M 4.7M 4.7M 546,468 569,940
Net Debt 4.5M 4.5M 2.2M -- --
Share Issued 332.9M 328.5M 328.5M 328.5M 325.3M
Ordinary Shares Number 332.9M 328.5M 328.5M 328.5M 325.3M
Accrued Interest Receivable -- -- -- -- 0.00
Capital Lease Obligations 0.00 95,766 521,341 546,468 569,940
Current Capital Lease Obligation 0.00 63,289 111,145 106,206 101,456
Current Deferred Liabilities 12.5M -- -- -- 0.00
Dueto Related Parties Current 1.5M -- -- -- 919,680
Machinery Furniture Equipment 212,535 -- -- -- 321,990
Non Current Prepaid Assets 223,860 223,860 223,860 223,860 223,860
Other Current Borrowings 3.7M 3.6M 3.4M -- --
Other Equity Interest 537,142 442,665 454,745 34,421 34,421
Other Properties -- 187,108 738,607 786,269 1.1M
Other Receivables 18,155 -- -- -- 39,756
Taxes Receivable 104,478 -- -- -- 258,348
Line Item Q4 2025Oct 31, 2025 Q3 2025Jul 31, 2025 Q2 2025Apr 30, 2025 Q1 2025Jan 31, 2025 Q4 2024Oct 31, 2024
Operating Cash Flow -171,126 -2.1M -3.8M -4.8M -3.9M
Cash Flow From Continuing Operating Activities -171,126 -2.1M -3.8M -4.8M -3.9M
Depreciation And Amortization 62,215 185,052 47,662 47,662 170,453
Depreciation Amortization Depletion 62,215 185,052 47,662 47,662 170,453
Stock Based Compensation 678,339 356,161 544,939 723,455 -399,369
Change In Working Capital 982,422 1.4M -715,775 113,290 1.5M
Change In Receivables 143,415 166,931 -59,691 -75,184 267,671
Change In Payables And Accrued Expense 823,934 859,058 -663,053 516,711 636,873
Other Non Cash Items 322,138 154,881 62,892 -16,175 -202,603
Purchase Of PPE -- -- -- -- 0.00
Net PPE Purchase And Sale 20,174 -- -- -- 0.00
Purchase Of Investment -- -- -- -- 0.00
Sale Of Investment 0.00 0.00 0.00 0.00 0.00
Net Investment Purchase And Sale 0.00 0.00 0.00 0.00 0.00
Investing Cash Flow 20,174 4,784 0.00 0.00 0.00
Cash Flow From Continuing Investing Activities 20,174 4,784 0.00 0.00 0.00
Issuance Of Debt 90,454 173,699 -- -- --
Repayment Of Debt -6,754 -20,262 -43,290 -42,450 -42,030
Net Issuance Payments Of Debt 83,700 153,437 4.6M -42,450 -42,030
Financing Cash Flow 332,339 153,437 4.6M 22,375 4.9M
Cash Flow From Continuing Financing Activities 332,339 153,437 4.6M 22,375 4.9M
Changes In Cash 181,387 -1.9M 790,143 -4.8M 993,070
Beginning Cash Position 83,617 2.0M 1.2M 6.0M 5.0M
End Cash Position 265,004 83,617 2.0M 1.2M 6.0M
Free Cash Flow -171,126 -2.1M -3.8M -4.8M -3.9M
Income Tax Paid Supplemental Data 0.00 225.00 9,178 0.00 0.00
Change In Prepaid Assets 15,073 330,352 6,969 -328,237 551,819
Gain Loss On Sale Of PPE -- -50,963 -- -- --
Long Term Debt Issuance 90,454 173,699 -- -- --
Long Term Debt Payments -6,754 -20,262 -43,290 -42,450 -42,030
Net Income From Continuing Operations -2.2M -4.1M -3.8M -5.7M -5.0M
Net Long Term Debt Issuance 83,700 153,437 924,265 -42,450 -42,030
Net Other Financing Charges 0.00 0.00 0.00 64,825 0.00
Net Other Investing Changes -- -- -- -- 0.00
Net Short Term Debt Issuance 0.00 0.00 -- -- --
Operating Gains Losses -- -- -- -- --
Proceeds From Stock Option Exercised 0.00 0.00 -- -- 0.00
Sale Of PPE 20,174 -- -- -- --
Short Term Debt Issuance 0.00 0.00 -- -- --
NEWS
Loading news...
TRENDING
Loading...